Biomarkers Point to Dementia Progression (CME/CE)
(MedPage Today) -- A biomarker model of the progression of Alzheimer's disease is supported by a clinical study of people with mild cognitive impairment, researchers reported.
Tags:
Biomarkers Point to Dementia Progression (CME/CE),
Alzheimer's Disease Latest News